IFRX

InflaRx N.V.

6 catalysts on file

IFRX

InflaRx N.V.

Phase 2 Confirmed

izicopan

ANCA-associated vasculitis

155d ago Mar 19, 2026

SEC 6-K verified 2mo ago

Countdown card →

IFRX

InflaRx N.V.

Catalyst AI-extracted

izicopan

hidradenitis suppurativa (HS)

155d ago Mar 19, 2026

SEC 6-K verified 2mo ago

Countdown card →

IFRX

InflaRx N.V.

AdCom AI-extracted

vilobelimab

pyoderma gangrenosum (PG)

146d ago Mar 28, 2026

SEC 6-K verified 2mo ago

Countdown card →

IFRX

InflaRx N.V.

Approval AI-extracted

vilobelimab

SARS-CoV-2-induced acute respiratory distress syndrome (ARDS)

52d ago Jun 30, 2026

SEC 6-K verified 2mo ago

Countdown card →

IFRX

InflaRx N.V.

Phase 1 AI-extracted

izicopan

atypical hemolytic uremic syndrome (aHUS)

Date TBD Date TBD

SEC 6-K verified 2mo ago

Countdown card →

IFRX

InflaRx N.V.

AdCom AI-extracted

izicopan

hidradenitis suppurativa (HS)

Date TBD Date TBD

SEC 6-K verified 2mo ago

Countdown card →